The PROMOTE study will assess whether a test product can improve insulin sensitivity in people with Type 2 diabetes. The test product is being developed as a medical food for people who may need additional support for blood glucose control.

Interested in enrolling? If you are interested in joining this research study, please complete this form to see if you qualify for the PROMOTE Study.

Interested participants may also call 704-273-5456 or email

Compensation is provided for completed study activities.

View the study flyer.

L. Kristin Newby, MD

Kannapolis Site Investigator:
L. Kristin Newby, MD

F. Greenway

Principal Investigator:
Frank L. Greenway, MD 

About the Study 

Eligible participants will be randomly assigned to receive either the test product or placebo.

Participants will be asked to take their assigned tablets twice a day for 84 days (12 weeks). Participants will need to record the time the tablets are taken as well as any adverse reactions or changes to medical condition during participation.

Study Qualifications

To qualify for this research study, participants should be:

  • Between the ages of 18–70 years old

  • Diagnosed with Type 2 diabetes and under the care of a healthcare professional for its management

Study Duration

Participation in the study will last approximately 15 weeks with six visits in either Kannapolis or Durham.

Study Design

Number of Visits:

  • 1 screening visit

  • 5 study visits


  • Medical history

  • Physical exam

  • Height and weight

  • Vital signs (pulse and blood pressure, etc.)

  • Blood samples

  • Urine samples


Compensation is provided for completed study activities.

In the News

Participants in Duke's PROMOTE Study Hope to Improve Care for Type 2 Diabetes